Torres, TFerreira, AFerreira, PHenriques, MLeite, LMagina, SMarques Pinto, GOliveira, HSousa Basto, ATavares Bello, RVarela, PMassa, ASelores, MFilipe, P2017-01-092017-01-092016-09Acta Med Port. 2016 Sep;29(9):574-577http://hdl.handle.net/10400.26/17366porAgentes BiológicosMedicamentos BiossimilaresPsoríase/tratamentoBiological AgentsBiosimilar PharmaceuticalsPsoriasis/drug therapyPortugalPortuguese Position Paper on the Use of Biosimilars in Psoriasisjournal article